Skip to main content
. Author manuscript; available in PMC: 2019 Jun 18.
Published in final edited form as: Mol Pharm. 2016 Dec 15;14(1):310–318. doi: 10.1021/acs.molpharmaceut.6b00937

Table 1.

Association of Genetic Variation in Transporters with Plasma TMAO Concentration

genotype no. of patients TMAO, μM mean (SD) pa
OCT2 (SLC22A2) c.808G>T
G/G 337 5.74 (5.68) 0.582
G/T; T/T 70 5.77 (5.89)
ABCB1 c.3435C>T
C/C 76 5.97 (5.79) 0.854
C/T 226 5.62 (5.93)
T/T 105 5.86 (5.20)
ABCC2 c.1249G>A
G/G 248 5.87 (6.03) 0.216
G/A 138 5.71 (5.24)
A/A 21 4.54 (4.86)
ABCG2 c.421C>A
C/C 332 5.45 (4.80) 0.116
C/A; A/A 74 7.15 (8.62)
a

p value calculated using Mann–Whitney U test or Kruskal–Wallis test with Dunn’s Multiple Comparison test as appropriate.